Agios to Present at the Citi 14th Annual Biotech Conference on Thursday, September 5, 2019 Read more about Agios to Present at the Citi 14th Annual Biotech Conference on Thursday, September 5, 2019
Agios at Citi 14th Annual Biotech Conference Read more about Agios at Citi 14th Annual Biotech Conference
Agios Reports Business Highlights and Second Quarter 2019 Financial Results Read more about Agios Reports Business Highlights and Second Quarter 2019 Financial Results
Agios to Webcast Conference Call of Second Quarter 2019 Financial Results on August 1, 2019 Read more about Agios to Webcast Conference Call of Second Quarter 2019 Financial Results on August 1, 2019
Q2 2019 Agios Pharmaceuticals Inc Earnings Conference Call Read more about Q2 2019 Agios Pharmaceuticals Inc Earnings Conference Call
Agios Announces Orlando Oliveira Appointed as Senior Vice President and General Manager, International Read more about Agios Announces Orlando Oliveira Appointed as Senior Vice President and General Manager, International
Agios at Goldman Sachs Global Healthcare Conference Read more about Agios at Goldman Sachs Global Healthcare Conference
Agios to Present at the Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019 Read more about Agios to Present at the Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019
Agios Announces the Planned Retirement of Chief Scientific Officer, Scott Biller, Ph.D., Effective December 31, 2019 Read more about Agios Announces the Planned Retirement of Chief Scientific Officer, Scott Biller, Ph.D., Effective December 31, 2019
Agios Presents Updated Data from Phase 1 Studies of TIBSOVO® (ivosidenib) in Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy Read more about Agios Presents Updated Data from Phase 1 Studies of TIBSOVO® (ivosidenib) in Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy